Article: Niagen® IV (NR IV) Is Safer, Faster, and More Effective Than NAD+ IV at Raising NAD+ Levels

Jun 10, 2024 Clinical Intravenous Pharmacokinetic/Safety

Niagen® IV (NR IV) Is Safer, Faster, and More Effective Than NAD+ IV at Raising NAD+ Levels

Objectives

To assess the safety and efficacy of a single intravenous administration of NR compared to NAD+ and a saline control in terms of whole blood NAD+ changes, tolerable infusion rates, and clinical chemistry safety profiles.

Journal

medRxiv

Key Outcomes

NR IV was safe, well-tolerated, and resulted in fewer and less severe adverse experiences compared to NAD+ IV.
NR IV increased NAD+ levels by 20.7% after three hours, outperforming both NAD+ IV and oral NR supplementation.
NR IV infusion time was 75% shorter than that of IV NAD+.
While NAD+ IV increased white blood cell and neutrophil counts, indicating a potential inflammatory response, NR IV showed no evidence of such a response.

Duration

24 hours

Dose

Single dose of 500 mg

Study Design

Randomized, double-blind, placebo-controlled pilot clinical study in healthy adults. The study included two phases, with data analyzed from 37 participants in the first phase and 16 participants in the second phase.

See Published Study

Cellular Health

Targeting Autophagy-NAD Pathway Protects Cells in Niemann-Pick Type C1 Disease: Preclinical Findings

SynopsisImpaired autophagy, which leads to the buildup of misfolded proteins and damaged organelles, has been linked to many human diseases. Loss of autophagy in metabolically active cells can caus...

Metabolic Health

A Novel Ketogenic Diet Reduces Seizure Severity and Prevents Fatty Liver in Epileptogenesis: Preclinical Findings

Synopsis Drug-resistant epilepsy remains difficult to manage, and while the ketogenic diet (KD) can help reduce seizures, its high fat content often causes metabolic side effects and poor patient ...